Related Experiment Video
Updated: Mar 30, 2026
Fabrication of Myogenic Engineered Tissue Constructs
Published on: May 1, 2009
Tissue Engineering for Pediatric Applications
Corin Williams1, Robert E Guldberg2
11 Department of Biomedical Engineering, Tufts University , Medford, Massachusetts.
Insights
Tissue engineering and regenerative medicine (TERM) offers unique opportunities to address severe birth defects in infants. Leveraging children's regenerative capacity can create living tissue replacements that grow with the child.
Area of Science:
- Regenerative Medicine
- Pediatric Health
- Biomedical Engineering
Background:
- Severe birth defects affect 2-3% of live births, causing significant mortality.
- Congenital malformations can impact any organ system, often with unknown etiologies.
- Existing treatments and synthetic materials are often unsuitable for pediatric patients due to growth limitations.
Purpose of the Study:
- To highlight the potential of tissue engineering and regenerative medicine (TERM) for pediatric applications.
- To address the unmet needs in treating congenital malformations in children.
- To emphasize the advantages of TERM strategies for the pediatric population.
Main Methods:
- Review of current challenges in pediatric regenerative medicine.
- Analysis of the unique biological characteristics of the pediatric population.
- Identification of opportunities for TERM in treating birth defects.
Main Results:
- Pediatric patients possess enhanced regenerative potential compared to adults.
- Synthetic materials often lack the necessary growth potential for pediatric applications.
- There is a critical shortage of pediatric donor organs, necessitating alternative solutions.
Conclusions:
- TERM holds immense promise for addressing severe birth defects in children.
- Leveraging pediatric regenerative capacity is key to developing effective TERM strategies.
- Developing living, functional tissue replacements that grow with the child is a critical need.
Abstract:
Severe birth defects occur in ∼ 2-3% of live-born infants and are a leading cause of death in the young. Structural malformations can occur in just about any major organ system and often their causes are unknown. The pediatric population presents a unique set of opportunities to the field of tissue engineering and regenerative medicine (TERM). Infants and young children have significantly greater regenerative capacity than adults, which could be leveraged in TERM strategies. Children also arguably stand to benefit the most from TERM. Although the lack of growth potential and relatively short life span of synthetic materials may be suitable for adults, it is unacceptable for children. Furthermore, given that there is a particular scarcity of pediatric donor organs, the need for living functional tissue replacements that can grow with the child is quite evident. There is enormous potential for the TERM community to address the needs of the pediatric population.
